PDS Biotechnology Corporation

NASDAQ:PDSB

Biotechnology

Healthcare
$0.92 +1.21%

+$0.01 today

Market cap
$51.58M
Beta
1.56
P/E (TTM)
-1.5
EPS (TTM)
-$0.60
52W Low $0.51High $1.67

Volume 5.25M

Average 1.04M

PDSB Pre-Tax Margin

Income before tax as a percentage of revenue.

No reported Pre-Tax Margin figures are available to summarize.

Pre-Tax Margin history

Percent of revenue · from the income statement

No Pre-Tax Margin data reported for this period type.

Pre-Tax Margin vs competitors

How PDSB compares with its peers on the latest reported figures

PDSB Competitors Peer median
Pre-Tax Margin for PDSB and competitors
Company Period LTM level YoY 3-year change
ATNMActinium Pharmaceuticals, Inc.LTM Jun 202632.2% —-34446.7 pp
XLOXilio Therapeutics, Inc.LTM Mar 2026-58.5% +527.0 pp—
INMBINmune Bio, Inc.FY2025-91866.0% +208719.7 pp-84566.8 pp
PDSBPDS Biotechnology CorporationFY2025— ——
OKUROnKure Therapeutics, Inc.FY2025— ——
ANVSAnnovis Bio, Inc.FY2025— ——
Peer median (excluding PDSB) -58.5%+104623.4 pp-59506.7 pp

Competitors are the stored peer set for PDSB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue0057.33K59.79K0
Gross Profit00(57.33K)(59.79K)0
Gross Margin—————
Research & Development11.25M29.43M27.76M22.57M19.03M
Selling, General & Admin10.18M12.24M15.28M13.7M12.52M
Operating Expenses21.44M41.67M43.05M36.26M31.54M
Depreciation & Amortization5.36K8657.33K59.79K21.84K
EBITDA(21.43M)(40.74M)(40.09M)(33.75M)(30.3M)
EBITDA Margin—————
Operating Income(21.44M)(41.67M)(43.05M)(36.32M)(31.54M)
Operating Margin—————
Interest Income4.35K935.18K2.9M2.52M1.22M
Interest Expense01.32M4.21M4.67M5.34M
Other Income / Expenses4.35K(381.34K)(1.3M)(2.16M)(4.12M)
Income Before Tax(21.43M)(42.05M)(44.35M)(38.48M)(35.67M)
Pre-Tax Margin—————
Income Tax Expense(4.52M)(1.2M)(1.41M)(869.17K)(1.17M)
Net Income(16.92M)(40.85M)(42.94M)(37.61M)(34.5M)
Net Margin—————
EPS (Basic)(0.66)(1.43)(1.39)(1.03)(0.74)
EPS (Diluted)(0.66)(1.43)(1.39)(1.03)(0.74)
Weighted Avg Shares25.6M28.6M30.95M36.45M46.38M
Weighted Avg Shares (Diluted)25.6M28.6M30.95M36.45M46.38M

PDS Biotechnology Corporation

NASDAQ:PDSB

Intrinsic Alpha fair value

Locked

Current Price

$0.92

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.